scholarly journals Empowering Family Awareness of Cardiovascular Disease in Ngangkrik Hamlet, Sleman Regency

2021 ◽  
Vol 7 (2) ◽  
pp. 137
Author(s):  
Erinda Nurrahma ◽  
Ailsa Nur Rahma Apta Widyadhana ◽  
Annisa Leny Saraswati ◽  
Ave Anugraheni ◽  
Muhammad Jourdan Prasetyatama ◽  
...  

Cardiovascular disease is the main cause of death worldwide and in Indonesia. Public awareness and acceptance of preventative cardiovascular care are crucial for reducing illness-related morbidity and mortality. As a result, community service is essential for the primary prevention of cardiovascular disease. Between April and July 2019, this community service was undertaken in Ngangkrik Hamlet, Sleman Regency, Yogyakarta Special Region (DIY). Ngangkrik locals participated in this program in three categories: Bapak Bijak (Wise Dads), Ibu Cerdas (Smart Moms), and Pemuda Bijak (Wise Youngsters). Five stages comprised this program: planning, informing, preparation, implementation, and oversight. Lectures/courses, discussions, practice, and roleplaying were used to implement the materials. To examine participants' knowledge, the pretest and posttest approach was utilized. The program raised participants' knowledge and understanding about the prevention and treatment of cardiovascular disease across all categories.

2009 ◽  
Vol 42 (19) ◽  
pp. 37
Author(s):  
WILLIAM E. GOLDEN ◽  
ROBERT H. HOPKINS

2020 ◽  
Vol 15 (6) ◽  
pp. 1-6
Author(s):  
Belinda Linden

Belinda Linden presents a quarterly overview of recently published guidance of relevance to cardiovascular nursing. A guideline on reducing cardiovascular risk through primary prevention in adults is reviewed in this update.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
N. Aerts ◽  
D. Le Goff ◽  
M. Odorico ◽  
J. Y. Le Reste ◽  
P. Van Bogaert ◽  
...  

Abstract Background Cardiovascular diseases are the world’s leading cause of morbidity and mortality. An active lifestyle is one of the cornerstones in the primary prevention of cardiovascular disease. An initial step in guiding primary prevention programs is to refer to clinical guidelines. We aimed to systematically review clinical practice guidelines on primary prevention of cardiovascular disease and their recommendations regarding physical activity. Methods We systematically searched Trip Medical Database, PubMed and Guidelines International Network from January 2012 up to December 2020 using the following search strings: ‘cardiovascular disease’, ‘prevention’, combined with specific cardiovascular disease risk factors. The identified records were screened for relevance and content. We methodologically assessed the selected guidelines using the AGREE II tool. Recommendations were summarized using a consensus-developed extraction form. Results After screening, 27 clinical practice guidelines were included, all of which were developed in Western countries and showed consistent rigor of development. Guidelines were consistent about the benefit of regular, moderate-intensity, aerobic physical activity. However, recommendations on strategies to achieve and sustain behavior change varied. Multicomponent interventions, comprising education, counseling and self-management support, are recommended to be delivered by various providers in primary health care or community settings. Guidelines advise to embed patient-centered care and behavioral change techniques in prevention programs. Conclusions Current clinical practice guidelines recommend similar PA lifestyle advice and propose various delivery models to be considered in the design of such interventions. Guidelines identify a gap in evidence on the implementation of these recommendations into practice.


Author(s):  
Shi Ying Tan ◽  
Heather Cronin ◽  
Stephen Byrne ◽  
Adrian O’Donovan ◽  
Antoinette Tuthill

Abstract Background Type 2 diabetes is associated with an increased cardiovascular risk. Use of aspirin has been shown to be of benefit for secondary prevention of cardiovascular disease in patients with type 2 diabetes; benefits in primary prevention have not been clearly proven. Aims This study aims to (a) determine if aspirin is prescribed appropriately in type 2 diabetes for primary or secondary prevention of cardiovascular disease (CVD) and (b) evaluate whether there are differences in aspirin prescribing according to where people receive their care. Design Cross-sectional study Methods The medical records of individuals with type 2 diabetes aged over 18 years and attending Elmwood Primary Care Centre and Cork University Hospital Diabetes outpatient clinics (n = 400) between February and August 2017 were reviewed. Results There were 90 individuals exclusively attending primary care and 310 persons attending shared care. Overall, 49.0% (n = 196) of those were prescribed aspirin, of whom 42.3% were using it for secondary prevention. Aspirin was used significantly more in people attending shared care (p < 0.001). About 10.8% of individuals with diabetes and CVD attending shared care met guidelines for, but were not prescribed aspirin. Conclusion A significant number of people with type 2 diabetes who should have been prescribed aspirin for secondary prevention were not receiving it at the time of study assessment. In contrast, a substantial proportion who did not meet criteria for aspirin use was prescribed it for primary prevention.


Sign in / Sign up

Export Citation Format

Share Document